Septischer Schock und systemisches Entzündungsreaktions-Syndrom - Therapie

Literatur

• 1 Alejandria M M, Lansang M A, Dans L F, Mantaring J B. Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Library). Oxford: Update Software In: The Cochrane Library 2001
• 2 Annane D, Sébille V, Charpentier C. et al . Effect of a treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.  JAMA. 2002;  288 862-871
• 3 Anonymus. Wirksamkeit von rekombinantem Erythropoietin (rhEPO) bei schwerkranken Patienten auf Intensivstationen.  Arzneimittelbrief. 2003;  37 29-30
• 4 Bernard G R, Vincent J -L, Laterne P F, LaRosa S P, Dhainaut J F, Lopez-Rodriguez A, Steingrub J S, Garber G E, Helterbrand J D, Ely E W, Fisher C J. Recombinant Human Protein C Worldwide Evaluation in Severe sepsis (PROWESS) Study group . Efficacy and safety of recombinant human activated protein C for severe sepsis.  N Engl J Med. 2001;  344 699-709
• 5 Bodmann K -F, Vogel F. Antimikrobielle Therapie der Sepsis - Empfehlungen einer Arbeitsgruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie eV.  Chemotherapie Journal. 2001;  10 43-55
• 6 Burchardi H, Briegel J, Eckart J, Hasenfuß G, Hermann H P, Holtz J, Meier-Hellmann A, Möllhoff T, Radermacher P, Roessler M, Speis C, Thiemermann C, Werdan K. Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin.  Anästhesiologie & Intensivmedizin. 2000;  41 557-631
• 7 Cohen J. The immunopathogenesis of sepsis.  Nature. 2002;  420 885-891
• 8 Dellinger R P. Cardiovascular management of septic shock.  Crit Care Med. 2003;  31 946-955
• 9 Friedman G, Silva E, Vincent J -L. Has the mortality of septic shock changed with time?.  Crit Care Med. 1998;  26 2078-2086
• 10 Holländer R. Humanmedizinische Bedeutung und Biologie der Staphylokokken.  Klinikarzt. 2002;  31 285-289
• 11 Hotchkiss R S, Karl I E. The pathophysiology and treatment of sepsis.  N Engl J Med. 2003;  348 138-150
• 12 International Sepsis Forum . Practical recommendations for the management of patients with severe sepsis and septic shock.  Intensive Care Med. 2001;  27/14 (suppl) 1-134
• 13 Joffe A R. Critical Care Medicine: Major changes in dogma of the past decade.  J Intensive Care. 2001;  16 177-192
• 14 Kollef M H. Optimizing antibiotic therapy in the intensive care unit setting.  Critical Care. 2001;  5 189-195
• 15 Kompetenznetz Sepsis SEP NET (Autoren: Bloos F, Brunkhorst FM, Meier-Hellmann A, Reinhart K) .Diagnose und Therapie der Sepsis - Empfehlungen in Anlehnung an die Richtlinien des International Sepsis Forum (ISF). Deutsche Sepsis-Gesellschaft, Version 3.6 2002
• 16 Kvetan V, Mustafa I, Dobb G. et al . Resuscitation of patients in septic shock - 1st Asia-Pacific Consensus Conference in Critical Care Medicine.  Intensive Care World. 1998;  15 72-83
• 17 Lark R L, Saint S, Chenoweth C. et al . Four-year evaluation of community-acquired bacteremia: Epidemiology, microbiology, and patient outcome.  Diagnostic Microbiology and Infectious Disease. 2001;  41 15-22
• 18 Müller-Werdan U, Werdan K. Septic cardiomyopathy.  Curr Opin Crit Care. 1999;  5 415-420
• 19 Rivers E, Nguyen B, Havstad S. et al . Early goal-directed therapy in the treatment of severe sepsis and septic shock.  N Engl J Med. 2001;  345 1368-1377
• 20 Sands K E, Bates D W, Lanken P N. et al . Epidemiology of sepsis syndrome in 8 academic medical centers.  JAMA. 1997;  278 234-240
• 21 Sibbald W J, Vincent J -L. Roundtable conference on clinical trials for the treatment of sepsis.  Chest. 1995;  107 522-527
• 22 Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine . Practice parameters for hemodynamic support of sepsis in adult patients in sepsis.  Crit Care Med. 1999;  27 639-660
• 23 Van den Berghe G, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-1367
• 24 Vincent J -L, Abraham E, Annane D. et al . Reducing mortality in sepsis: new directions.  Critical Care. 2002;  6 (suppl 3) S1-S18 , (online: http://ccforum.com/content/6/S3/S1)
• 25 Werdan K. Assessment of ivIG for prophylaxis and therapy of sepsis.  Curr Opin Crit Care. 2001;  7 354-361